Protein Kinase Inhibitors: all 15,278 studies that test it

Page 61 of 153. Open to participants first (2,556), then studies with results posted, then the rest; newest registration first within each.

• Concentration and Activity of Lapatinib in Vestibular SchwannomasCompletedNCT00863122Early Phase 1Results posted
• Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)TerminatedNCT00862836Phase 1/2Results posted
• Pazopanib Hydrochloride in Treating Patients With Metastatic Melanoma That Cannot be Removed by SurgeryCompletedNCT00861913Phase 2Results posted
• Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate CancerTerminatedNCT00861471Phase 1/2Results posted
• Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate CancerTerminatedNCT00860158Phase 2Results posted
• Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland TumorsCompletedNCT00859937Phase 2Results posted
• Sunitinib in Certain Subtypes of Soft Tissue SarcomasTerminatedNCT00859456Phase 2Results posted
• Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCCTerminatedNCT00859339Phase 2Results posted
• Clinical Studies on Bile Acids in Barrett's EsophagusCompletedNCT00858858Not applicableResults posted
• Dasatinib in Advanced Non-small Cell Lung Cancer (NSCL) With Ex Vivo and In Vivo Assessment of Tumor Target ModulationTerminatedNCT00858403Phase 2Results posted
• Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the BreastTerminatedNCT00857714Not applicableResults posted
• The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular DegenerationTerminatedNCT00857259Phase 2Results posted
• A Study Comparing 2 Doses Of CP-690,550 Vs. Placebo For The Treatment Of Rheumatoid Arthritis In Patients On Other Background Arthritis MedicationsCompletedNCT00856544Phase 3Results posted
• A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung CancerCompletedNCT00855894Phase 2Results posted
• A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).CompletedNCT00855218Phase 2Results posted
• Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerCompletedNCT00854620Phase 2Results posted
• A Phase 3 Study Comparing 2 Doses Of CP-690,550 And The Active Comparator, Humira (Adalimumab) Vs. Placebo For Treatment Of Rheumatoid ArthritisCompletedNCT00853385Phase 3Results posted
• AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With SunitinibCompletedNCT00853372Phase 2Results posted
• MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal CarcinomaCompletedNCT00853307Phase 2Results posted
• Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney CancerTerminatedNCT00853125Phase 2Results posted
• Treatment With Pazopanib for Neoadjuvant Breast CancerCompletedNCT00849472Phase 2Results posted
• Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerCompletedNCT00849186Not applicableResults posted
• Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryCompletedNCT00848016Phase 2Results posted
• A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background MethotrexateCompletedNCT00847613Phase 3Results posted
• Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerCompletedNCT00847015Phase 2Results posted
• Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular CarcinomaCompletedNCT00844883Phase 2Results posted
• RAD001 and Erlotinib in Patients With Neuroendocrine TumorsTerminatedNCT00843531Phase 2Results posted
• A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell LymphomaTerminatedNCT00843050Phase 2Results posted
• Study Of Sunitinib In Patients With Recurrent Paraganglioma/PheochromocytomaCompletedNCT00843037Phase 2Results posted
• A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid TumorsCompletedNCT00842335Phase 1/2Results posted
• Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00842244Phase 1Results posted
• Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ PatientsCompletedNCT00841828Phase 2Results posted
• 7 Day's of Erlotinib Neo-adjuvant, Followed by Adjuvant Erlotinib-gemcitabine in Pancreatic Cancer PatientsTerminatedNCT00841035Phase 2Results posted
• Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian OriginTerminatedNCT00840450Phase 2Results posted
• A Study for Participants With Pancreatic CancerCompletedNCT00839332Phase 1/2Results posted
• Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid TumorsCompletedNCT00838539Phase 1Results posted
• Sorafenib and Erlotinib in Treating Patients With Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00837876Phase 2Results posted
• Sorafenib and Dacarbazine in Soft Tissue SarcomaCompletedNCT00837148Phase 2Results posted
• Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)TerminatedNCT00836927Phase 2Results posted
• Axitinib (AG-013736) With Or Without Dose Titration (Increase) In Patients With Kidney CancerCompletedNCT00835978Phase 2Results posted
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by SurgeryTerminatedNCT00835679Early Phase 1Results posted
• Bendamustine and Erlotinib in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Breast CancerCompletedNCT00834678Phase 1/2Results posted
• E7080 in Combination With Carboplatin and Paclitaxel in Patients With Non-small Cell Lung Cancer (NSCLC)CompletedNCT00832819Phase 1Results posted
• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• TKI258 in Castrate Resistant Prostate CancerCompletedNCT00831792Phase 2Results posted
• Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney RemovalTerminatedNCT00831480Phase 2Results posted
• A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic SyndromeCompletedNCT00830518Phase 2Results posted
• Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical TrialsCompletedNCT00828919Not applicableResults posted
• Sorafenib and Vinorelbine in Treating Women With Stage IV Breast CancerCompletedNCT00828074Phase 1/2Results posted
• Trial of RAD001 in Triple Negative Metastatic Breast CancerTerminatedNCT00827567Phase 2Results posted
• A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for CancerCompletedNCT00827372Phase 2Results posted
• Biomarker Trial of Everolimus in Patients With Advanced Renal Cell CarcinomaCompletedNCT00827359Phase 2Results posted
• Sorafenib and Bevacizumab in Treating Patients With Metastatic Colorectal CancerCompletedNCT00826540Phase 2Results posted
• Dasatinib and Erlotinib in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00826449Phase 1/2Results posted
• 6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or TrastuzumabCompletedNCT00826267Phase 2Results posted
• Dose-Dense Temozolomide + Lapatinib for Recurrent EpendymomaCompletedNCT00826241Phase 2Results posted
• Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast CancerCompletedNCT00825734Phase 1/2Results posted
• Study of Gefitinib Retreatment in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00824746Phase 2Results posted
• Sunitinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Who Have Tumor Cells in the Bone MarrowTerminatedNCT00824538Phase 2Results posted
• Trial of BI 6727 (Volasertib) Monotherapy and BI 6727 in Combination With Pemetrexed Compared to Pemetrexed Monotherapy in Advanced NSCLCCompletedNCT00824408Phase 2Results posted
• Everolimus in Treating Patients With Recurrent Low-Grade GliomaCompletedNCT00823459Phase 2Results posted
• Gemzar, Cisp, Sunitinib Urothelial CaCompletedNCT00821327Phase 2Results posted
• A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque PsoriasisCompletedNCT00820950Phase 2Results posted
• Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast CancerCompletedNCT00820222Phase 3Results posted
• Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194CompletedNCT00820170Phase 1/2Results posted
• Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The LungCompletedNCT00818441Phase 2Results posted
• Efficacy Study of Dasatinib in Locally Advanced Triple-Negative Breast Cancer PatientsTerminatedNCT00817531Phase 2Results posted
• Study of Sorafenib/Cetuximab in Head and Neck CancerCompletedNCT00815295Phase 1/2Results posted
• Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate CancerCompletedNCT00814788Phase 2Results posted
• A Phase 3 Study Comparing 2 Doses of CP-690,550 vs. Placebo for Treatment of Rheumatoid ArthritisCompletedNCT00814307Phase 3Results posted
• Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular CancerCompletedNCT00813293Phase 2Results posted
• Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers SyndromeTerminatedNCT00811590Phase 2Results posted
• Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive LeukemiasCompletedNCT00811070Phase 2Results posted
• Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic CancerCompletedNCT00810719Phase 2Results posted
• Sorafenib in Treating Patients With Advanced Malignant Solid TumorsCompletedNCT00810394Phase 2Results posted
• RAD001(Everolimus) in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00809185Phase 2Results posted
• Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid TumoursCompletedNCT00809133Phase 1Results posted
• Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk NeuroblastomaTerminatedNCT00808899Phase 2Results posted
• Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's LymphomaCompletedNCT00807495Phase 2Results posted
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCCompletedNCT00806819Phase 3Results posted
• RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBMCompletedNCT00805961Phase 2Results posted
• Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 StudiesTerminatedNCT00805467Phase 2Results posted
• LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung CancerCompletedNCT00805194Phase 3Results posted
• Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the UrotheliumCompletedNCT00805129Phase 2Results posted
• Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid LeukaemiaCompletedNCT00804856Phase 2Results posted
• Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT00803010Phase 2Results posted
• Randomized Phase Lll Study of Imatinib Dose Optimization vs Nilotinib in CML Patients With Suboptimal Response to ImatinibCompletedNCT00802841Phase 3Results posted
• Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLCTerminatedNCT00801801Phase 2Results posted
• Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic TumorsCompletedNCT00800345Phase 1Results posted
• A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain MetastasisCompletedNCT00800202Phase 2Results posted
• Rollover Protocol for Prior SU011248 ProtocolsCompletedNCT00798889Not applicableResults posted
• Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell LymphomaCompletedNCT00798096Phase 2Results posted
• Trial of Sunitinib for Refractory Malignant AscitesTerminatedNCT00796861Phase 2Results posted
• BIBW2992 (Afatinib) in Advanced (EGFR-FISH +) NSCLC (Non Small Cell Lung Cancer) PatientsCompletedNCT00796549Phase 2Results posted
• Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)CompletedNCT00795886Phase 2Results posted
• Cediranib, Paclitaxel, and Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00795340Phase 3Results posted
• Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00795002Phase 2Results posted
• Bacillus Calmette-Guerin Followed by Sunitinib for the Treatment of High Risk Non-muscle Invasive Lower Urinary Tract Urothelial CarcinomaCompletedNCT00794950Phase 2Results posted
• Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal TumorCompletedNCT00793871Phase 4Results posted
• Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast CancerTerminatedNCT00793546Phase 2Results posted

← Protein Kinase Inhibitors overview